These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4758830)

  • 1. Bactericidal effect of combinations of nalidixic acid and various antibiotics on Enterobacteriaceae.
    Michel J; Luboshitzky R; Sacks T
    Antimicrob Agents Chemother; 1973 Sep; 4(3):201-4. PubMed ID: 4758830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergism of nalidixic acid with other broad spectrum antibiotics.
    Piccolomini R; Cellini L; Allocati N; Ravagnan G
    Chemioterapia; 1984 Apr; 3(2):103-7. PubMed ID: 6532536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal effect of combinations of antibiotics on Klebsiella-Enterobacter-Serratia.
    Luboshitzky R; Sacks T; Michel J
    Chemotherapy; 1973; 19(6):354-66. PubMed ID: 4794085
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-resistance of nalidixic acid resistant Enterobacteriaceae to new quinolones and other antimicrobials.
    Piddock LJ; Diver JM; Wise R
    Eur J Clin Microbiol; 1986 Aug; 5(4):411-5. PubMed ID: 3758052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism between fosfomycin and nalidixic acid in vitro.
    Ullmann U
    J Antimicrob Chemother; 1979 Sep; 5(5):612-3. PubMed ID: 115834
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to ten different fluoroquinolone antibiotics following in vitro exposures to nalidixic acid.
    Barry AL; Gardiner RV; Packer RR
    Diagn Microbiol Infect Dis; 1987 Jan; 6(1):77-9. PubMed ID: 3802748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of the in vitro sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa to 7 antimicrobial agents].
    Lynch MB; Mimica I; Valenzuela MC; Vilches A; Abarca S
    Rev Med Chil; 1972 Jan; 100(1):14-5. PubMed ID: 4622217
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro sensitivity pattern of gram negative pathogens to nalidixic acid.
    Chitkara YK
    Indian J Pathol Bacteriol; 1969 Oct; 12(4):162-8. PubMed ID: 4990210
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility of shigellae to mecillinam, nalidixic acid, trimethoprim, and five other antimicrobial agents.
    Hansson HB; Walder M; Juhlin I
    Antimicrob Agents Chemother; 1981 Feb; 19(2):271-3. PubMed ID: 6289727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclomycin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity.
    Nishida M; Mine Y; Matsubara T; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1972 Oct; 25(10):582-93. PubMed ID: 4567453
    [No Abstract]   [Full Text] [Related]  

  • 12. Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.
    Glew RH; Pavuk RA
    Antimicrob Agents Chemother; 1984 Sep; 26(3):378-81. PubMed ID: 6508266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synergistic activity of some chinolinic compounds combined with beta-lactam antibiotics against gram-positive and gram-negative clinical isolates.
    Ravagnan G; Piccolomini R; Speciale AM; Russo G; Renzini G
    Chemotherapy; 1985; 31(3):191-9. PubMed ID: 3996087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferable and non-transferable drug resistance in enteric bacteria from hospital and from general practice.
    Moller JK; Bak AL; Bülow P; Christiansen C; Christiansen G; Stenderup A
    Scand J Infect Dis; 1976; 8(2):112-6. PubMed ID: 775619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [General effects of antibiotic associations on certain Enterobacteriaceae (Escherichia, Salmonella, Klebsiella)].
    Cluzel R; Michel J; Cluzel M; Sirot J
    Pathol Biol (Paris); 1971; 19(11):627-36. PubMed ID: 4933627
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro studies of S-25930 and S-25932, two new 4-quinolones.
    Piddock LJ; Andrews JM; Diver JM; Wise R
    Eur J Clin Microbiol; 1986 Jun; 5(3):303-10. PubMed ID: 2943589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of shigella to nalidixic acid & fluorinated quinolones.
    Thirunarayanan MA; Jesudason MV; John TJ
    Indian J Med Res; 1993 Nov; 97():239-41. PubMed ID: 8144205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of enoxacin compared with norfloxacin and amikacin.
    van der Auwera P; de Moor G; Lacroix G; Mambour A; Rossion N; Schuyteneer F
    Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae.
    Brennan-Krohn T; Pironti A; Kirby JE
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of antibiotic resistance in shigellae isolated in The Netherlands 1984-1989.
    Voogd CE; Schot CS; van Leeuwen WJ; van Klingeren B
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):164-7. PubMed ID: 1396730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.